Abstract

PurposeThe world is shifting towards the fourth industrial revolution (Industry 4.0), symbolising the move to digital, fully automated habitats and cyber-physical systems. Industry 4.0 consists of innovative ideas and techniques in almost all sectors, including Smart health care, which recommends technologies and mechanisms for early prediction of life-threatening diseases. Cardiovascular disease (CVD), which includes stroke, is one of the world’s leading causes of sickness and deaths. As per the American Heart Association, CVDs are a leading cause of death globally, and it is believed that COVID-19 also influenced the health of cardiovascular and the number of patients increases as a result. Early detection of such diseases is one of the solutions for a lower mortality rate. In this work, early prediction models for CVDs are developed with the help of machine learning (ML), a form of artificial intelligence that allows computers to learn and improve on their own without requiring to be explicitly programmed.Design/methodology/approachThe proposed CVD prediction models are implemented with the help of ML techniques, namely, decision tree, random forest, k-nearest neighbours, support vector machine, logistic regression, AdaBoost and gradient boosting. To mitigate the effect of over-fitting and under-fitting problems, hyperparameter optimisation techniques are used to develop efficient disease prediction models. Furthermore, the ensemble technique using soft voting is also used to gain more insight into the data set and accurate prediction models.FindingsThe models were developed to help the health-care providers with the early diagnosis and prediction of heart disease patients, reducing the risk of developing severe diseases. The created heart disease risk evaluation model is built on the Jupyter Notebook Web application, and its performance is calculated using unbiased indicators such as true positive rate, true negative rate, accuracy, precision, misclassification rate, area under the ROC curve and cross-validation approach. The results revealed that the ensemble heart disease model outperforms the other proposed and implemented models.Originality/valueThe proposed and developed CVD prediction models aims at predicting CVDs at an early stage, thereby taking prevention and precautionary measures at a very early stage of the disease to abate the predictive maintenance as recommended in Industry 4.0. Prediction models are developed on algorithms’ default values, hyperparameter optimisations and ensemble techniques.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.